Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7377097
Reference Type
Journal Article
Title
Objectives, design and main findings until 2020 from the Rotterdam Study
Author(s)
Ikram, MA; Brusselle, G; Ghanbari, M; Goedegebure, A; Ikram, MK; Kavousi, M; Kieboom, BCT; Klaver, CCW; de Knegt, RJ; Luik, AI; Nijsten, TEC; Peeters, RP; van Rooij, FJA; Stricker, BH; Uitterlinden, AG; Vernooij, MW; Voortman, T
Year
2020
Is Peer Reviewed?
Yes
Journal
European Journal of Epidemiology
ISSN:
0393-2990
EISSN:
1573-7284
Volume
35
Issue
5
Page Numbers
483-517
Language
English
PMID
32367290
DOI
10.1007/s10654-020-00640-5
Web of Science Id
WOS:000530180300001
Abstract
The Rotterdam Study is an ongoing prospective cohort study that started in 1990 in the city of Rotterdam, The Netherlands. The study aims to unravel etiology, preclinical course, natural history and potential targets for intervention for chronic diseases in mid-life and late-life. The study focuses on cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. Since 2016, the cohort is being expanded by persons aged 40 years and over. The findings of the Rotterdam Study have been presented in over 1700 research articles and reports. This article provides an update on the rationale and design of the study. It also presents a summary of the major findings from the preceding 3 years and outlines developments for the coming period.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity